PTOV1 and prostate neoplasm: These analyses reveal that primary prostate tumors show significantly higher expression of PTOV1, CCNG2 and MYC compared to benign tissue (GSE29079), and PTOV1 levels significantly correlate with CCNG2 and MYC mRNA levels (Figure 5A and 5B).